Drugs like semaglutide, also known by the brand names Ozempic and Wegovy, have transformed how we treat obesity, but soaring demand has led to frequent supply shortages. In the US ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.